Therefore, targeting enzymes involved in pyrimidine metabolism, such as DHODH and thymidylate synthetase (TYMS), has emerged as a promising approach for the development of novel cancer therapies for peritoneal cancers, including ovarian cancer [87]. The gene discussed is TYMS; the disease is peritoneum cancer.